Clinical Trials Directory

Trials / Conditions / Growth Disorders

Growth Disorders

62 registered clinical trials studyying Growth Disorders4 currently recruiting.

StatusTrialSponsorPhase
RecruitingImpact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months
NCT06662045
Pingshan District Maternal & Child Healthcare Hospital of Shenzhen
UnknownRandomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513
Northwell HealthPhase 3
RecruitingThe Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
NCT06037473
Beijing Children's Hospital
Active Not RecruitingThe Effect of Interaction-Based Early Education Program Applied to Grandparents on the Grandchildren's Health
NCT05916144
Marmara UniversityN/A
CompletedNiPPeR Randomised Trial - Child Follow Up Study
NCT05934422
University of SouthamptonN/A
UnknownGrowth Chart Parameters, Risk Factors
NCT05841264
Assiut University
CompletedEvaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns
NCT06329388
TruHeight VitaminsPhase 1 / Phase 2
CompletedUse of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles
NCT05643274
Nantes University Hospital
UnknownGrowth Pattern and Characteristics of Cardiac Pediatric Patients
NCT05577130
Assiut University
CompletedImpact of Screens on Children's Growth
NCT07026812
University Hospital, Rouen
Active Not RecruitingGrowth Hormone in a Patient With a Dominant-Negative GHR Mutation
NCT05382637
Children's National Research InstitutePhase 2
CompletedChild Growth and Development in East London
NCT05419336
Queen Mary University of London
Active Not RecruitingEvolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain Development
NCT05242224
Washington University School of MedicineN/A
Active Not RecruitingPROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
NCT05033119
Ulla Schierup Nielsen
CompletedHealth and Nutrition Survey on Shenzhen Children
NCT05244785
Shenzhen Center for Chronic Disease Control
UnknownPattern of Growth and Characteristics of Down Syndrome Pediatrics Patients
NCT05056285
Assiut University
CompletedTesting the Feasibility of a Novel Growth Monitoring Smartphone App
NCT05829252
Queen Mary University of London
UnknownThe Effect of Early Childhood Cow's Milk Allergy Elimination Diet on Eating Behaviors, Nutrition, and Growth S
NCT04576845
Saglik Bilimleri Universitesi
Active Not RecruitingIs There a Microbiome Associated With Poor Growth in Preterm Infants?
NCT03761498
University of Texas Southwestern Medical Center
UnknownEvaluation of Digital Follow up of Preterm Infants
NCT05238168
Turku University Hospital
WithdrawnLong Term Effects of Nutritional Supplementation on Final Height
NCT03323177
Rabin Medical CenterN/A
TerminatedStudy to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone D
NCT03274973
Ferring Pharmaceuticals
UnknownBone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray
NCT03123003
Meir Medical CenterN/A
RecruitingIdentifying New Genetic Causes to Development Disorders
NCT03283852
Fondation Ophtalmologique Adolphe de Rothschild
UnknownEvaluation of NICHE Programme Activities in Kenya
NCT03518593
Kimetrica LLCN/A
CompletedLong-Acting Growth Hormone in Children Compared to Daily rhGH
NCT02339090
Versartis Inc.Phase 3
TerminatedVersartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting G
NCT02413138
Versartis Inc.Phase 2 / Phase 3
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia
NCT02208076
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East
NCT02015286
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore
NCT02015273
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece
NCT01363674
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
NCT01582334
Merck KGaA, Darmstadt, Germany
CompletedEffect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants
NCT03181178
Nevin Scrimshaw International Nutrition FoundationN/A
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain
NCT01376921
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
NCT01402999
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico
NCT01555528
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
NCT01439061
Merck KGaA, Darmstadt, Germany
CompletedLevel of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Trea
NCT01438528
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
NCT01400984
Merck KGaA, Darmstadt, Germany
CompletedLevel of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
NCT01400997
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria
NCT01296425
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden
NCT01307059
Merck KGaA, Darmstadt, Germany
CompletedA Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pedia
NCT01267526
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia
NCT01309555
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea
NCT01259778
Merck KGaA, Darmstadt, Germany
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
NCT01291394
Merck KGaA, Darmstadt, Germany
CompletedPromotion of Complimentary Feeding Practices in Bangladesh
NCT03024710
International Centre for Diarrhoeal Disease Research, BangladeshN/A
CompletedTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
NCT01263457
Merck KGaA, Darmstadt, Germany
CompletedEvaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agen
NCT00334945
University of Alabama at Birmingham
CompletedSaizen® E-Device User Trial
NCT00450190
Merck KGaA, Darmstadt, GermanyPhase 3
TerminatedTreatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency
NCT00330668
IpsenPhase 3
CompletedRecombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Defici
NCT00125190
IpsenPhase 2 / Phase 3
UnknownEffects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
NCT00473187
University of RostockPhase 1
CompletedNutrients and Hormones: Effects in Boys With Disordered Growth
NCT00139451
Nemours Children's ClinicPhase 2
CompletedPrepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficien
NCT00125164
IpsenPhase 3
CompletedThe Effect of Milk and Meat on IGFs in Prepubertal Boys
NCT00378859
University of CopenhagenN/A
RecruitingCrescNet - Growth Monitoring Network
NCT03072537
University of Leipzig
CompletedPilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children
NCT00004793
National Center for Research Resources (NCRR)
CompletedGenotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605
PfizerPhase 3
CompletedTreatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408
PfizerPhase 3
CompletedNational Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nut
NCT00097539
Genentech, Inc.
No Longer AvailableExpanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies
NCT03317366
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)